Patent US5174286A successfully refreshed from Google Patents.
US5174286A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Sensor for right ventricular and thoracic volumes using the trailing edge value of a generated pulse
Assignee: Individual
•
Filing: 1990-12-07
•
Granted: 1992-12-29
•
Expires: 2010-12-07
Abstract
Abstract A sensor for developing a control signal to be injected into the mechanism of a cardiac diagnosis and therapy device is disclosed. An external or internal pulse generator associated with the sensor includes a pulse width timer and an oscillator circuit to deliver constant voltage pulses through a capacitor to a lead for delivery of therapy or diagnosis. Means for detecting the peak trailing edge voltage or the current are included as an indicator of the volume of blood present in the heart or the thoracic volume at the time of stimulation. The volume signal is then directed to implantable or external devices by a control signal output to be used in the circuit of the other device.
Inventors
- 👤 Raul Chirife
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 06:03
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/36; A61N1/362; A61N1/365; A61N1/36514
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
126 words
Apparatus for applying therapy to a patient, comprising in combination: (a) pulse generator means for producing square wave pulses; (b) stimulating lead means for applying stimulating pulses to body tissues; (c) capacitor means connected to said pulse generator means for delivering said square wave pulses to said lead means; (d) integrator means coupled to said capacitor means for determining a parameter of a trailing edge signal resultant from said square wave pulses, said integrator means including a reset means for terminating integration of said trailing edge signal; (e) peak detector means connected to said integrator means for detecting a maximum value achieved of said parameter of said trailing edge signal; and (f) means connected to said peak detector means for outputting the peak detected maximum value.
Claim 2
Dependent Claim
126 words
Apparatus for applying therapy to a patient, comprising in combination: (a) pulse generator means for producing square wave pulses; (b) stimulating lead means for applying stimulating pulses to body tissues; (c) capacitor means connected to said pulse generator means for delivering said square wave pulses to said lead means; (d) integrator means coupled to said capacitor means for determining a parameter of a trailing edge signal resultant from said square wave pulses, said integrator means including a reset means for terminating integration of said trailing edge signal; (e) peak detector means connected to said integrator means for detecting a maximum value achieved of said parameter of said trailing edge signal; and (f) means connected to said peak detector means for outputting the peak detected maximum value.
Claim 3
Dependent Claim
29 words
The apparatus as in claim 1, wherein said reset means includes means for removing antifact by developing a control signal from a fixed percentage of said square wave pulse.
Claim 4
Dependent Claim
124 words
Apparatus for applying therapy to a patient, comprising in combination: (a) pulse generator means for producing square wave pulses; (b) stimulating lead means for applying stimulating pulses to body tissue; (c) capacitor means connected to said pulse generator means for delivering said square wave pulses to said lead means; (d) integrator means coupled to said capacitor means for determining a trailing edge voltage resultant form said square wave pulses, said integrator means including a reset means for terminating integration of said trailing edge voltage; (e) voltage peak detector means connected to said integrator means for detecting the maximum voltage achieved for said trailing edge voltage; and (f) means connected to said voltage peak detector means for outputting the peak detected trailing edge voltage signal.
Claim 5
Dependent Claim
124 words
Apparatus for applying therapy to a patient, comprising in combination: (a) pulse generator means for producing square wave pulses; (b) stimulating lead means for applying stimulating pulses to body tissue; (c) capacitor means connected to said pulse generator means for delivering said square wave pulses to said lead means; (d) integrator means coupled to said capacitor means for determining a trailing edge voltage resultant form said square wave pulses, said integrator means including a reset means for terminating integration of said trailing edge voltage; (e) voltage peak detector means connected to said integrator means for detecting the maximum voltage achieved for said trailing edge voltage; and (f) means connected to said voltage peak detector means for outputting the peak detected trailing edge voltage signal.
Claim 6
Dependent Claim
19 words
The apparatus as in either claim 1 or claim 3 wherein said stimulating lead means is a bipolar lead.
Claim 7
Dependent Claim
19 words
The apparatus as in either claim 1 or claim 3, wherein said stimulating lead means is a unipolar lead.
Claim 8
Dependent Claim
29 words
The apparatus as in claim 3, wherein said reset means includes means for removing antifact by developing a control signal from a fixed percentage of said square wave pulse.
Claim 9
Independent Claim
86 words
A method of producing a control signal for an apparatus for applying treatment to a patient comprising: (a) producing an output signal pulse; (b) applying said output signal pulse to tissue of the patient to be stimulated by way of a coupling capacitor and a stimulating lead; (c) sensing a parameter of a trailing edge signal resultant from said output signal pulse developed across said coupling capacitor; and (d) using the sensed parameter of the trailing edge signal to determine an intracardiac volume of the patient.
Claim 10
Independent Claim
86 words
A method of producing a control signal for an apparatus for applying treatment to a patient comprising: (a) producing an output signal pulse; (b) applying said output signal pulse to tissue of the patient to be stimulated by way of a coupling capacitor and a stimulating lead; (c) sensing a parameter of a trailing edge signal resultant from said output signal pulse developed across said coupling capacitor; and (d) using the sensed parameter of the trailing edge signal to determine an intracardiac volume of the patient.
Claim 11
Dependent Claim
12 words
A method as in claim 7 wherein said treatment is cardiac pacing.
Claim 12
Dependent Claim
12 words
A method as in claim 7 wherein said treatment is drug delivery.
Claim 13
Dependent Claim
28 words
The method of claim 7 further comprising the step of: (e) using the sensed parameter of the trailing edge signal to determine an intrathoracic volume of the patient.
Claim 14
Dependent Claim
104 words
In an implantable cardiac rhythm management device of the type comprising pulse generating means for producing output pulses and means including an output capacitor and a pacing lead for coupling said output pulses to tissue of a patient to be stimulated, said device including an improved physiologic sensor comprising: (a) means for deriving a control signal corresponding to a parameter of a trailing edge signal resultant from the pulse signals applied to said tissue; and (b) means for determining an intracardiac volume of a patient the device is adapted to as a function of said control signal and providing a first output indicative thereof.
Claim 15
Dependent Claim
104 words
In an implantable cardiac rhythm management device of the type comprising pulse generating means for producing output pulses and means including an output capacitor and a pacing lead for coupling said output pulses to tissue of a patient to be stimulated, said device including an improved physiologic sensor comprising: (a) means for deriving a control signal corresponding to a parameter of a trailing edge signal resultant from the pulse signals applied to said tissue; and (b) means for determining an intracardiac volume of a patient the device is adapted to as a function of said control signal and providing a first output indicative thereof.
Claim 16
Dependent Claim
36 words
The device as specified in claim 11 wherein said determining means further comprises means for determining stroke volume of a heart of the patient the device is adapted to as a function of said first output.
Claim 17
Dependent Claim
36 words
The device as specified in claim 11 wherein said determining means further comprises means for determining cardiac output of a heart of the patient the device is adapted to as a function of said first output.
Claim 18
Dependent Claim
37 words
The device as specified in claim 11 wherein said determining means further comprises means for determining ventricular ejection fraction of a heart of the patient the device is adapted to as a function of said first output.
Claim 19
Dependent Claim
105 words
In an implantable cardiac rhythm management device of the type comprising pulse generating means for producing output pulses and means including an output capacitor and a pacing lead for coupling said output pulses to tissue of a patient to be stimulated, said device including an improved physiologic sensor comprising: (a) a means for deriving a control signal corresponding to a parameter of a trailing edge signal resultant from the pulse signals applied to the tissue; and (b) means for determining a thoracic volume of a patient the device is adapted to as a function of said control signal and providing a first output indicative thereof.
Claim 20
Dependent Claim
105 words
In an implantable cardiac rhythm management device of the type comprising pulse generating means for producing output pulses and means including an output capacitor and a pacing lead for coupling said output pulses to tissue of a patient to be stimulated, said device including an improved physiologic sensor comprising: (a) a means for deriving a control signal corresponding to a parameter of a trailing edge signal resultant from the pulse signals applied to the tissue; and (b) means for determining a thoracic volume of a patient the device is adapted to as a function of said control signal and providing a first output indicative thereof.
Claim 21
Dependent Claim
32 words
The device as specified in claim 11 or 15 wherein said determining means adjusts a characteristic of said output pulses from said pulse generating means as a function of said first output.
Claim 22
Dependent Claim
33 words
The device as specified in claim 15 wherein said determining means further comprises means for determining tidal volume of the patient the device is adapted to as a function of the first output.
Claim 23
Dependent Claim
33 words
The device as specified in claim 15 wherein said determining means further comprises means for determining minute ventilation of the patient the device is adapted to as a function of the first output.
Claim 24
Independent Claim
94 words
A method of cardiac monitoring a patient comprising: (a) producing an output signal pulse; (b) applying said output signal pulse to tissue of the patient to be stimulated by way of a coupling capacitor and a stimulating lead; (c) sensing a parameter of a trailing edge signal resultant from said output signal pulse developed across said coupling capacitor; (d) using the sensed parameter of the trailing edge signal to determine an intracardiac volume of the patient; and (e) producing a first output signal indicative of the determined intracardiac volume for monitoring of the patient.
Claim 25
Independent Claim
94 words
A method of cardiac monitoring a patient comprising: (a) producing an output signal pulse; (b) applying said output signal pulse to tissue of the patient to be stimulated by way of a coupling capacitor and a stimulating lead; (c) sensing a parameter of a trailing edge signal resultant from said output signal pulse developed across said coupling capacitor; (d) using the sensed parameter of the trailing edge signal to determine an intracardiac volume of the patient; and (e) producing a first output signal indicative of the determined intracardiac volume for monitoring of the patient.
References Cited (Backward Citations)
US3713449A
Cited
US4141367A
Cited
US4226245A
Cited
US4337776A
Cited
US4364396A
Cited
US4686987A
Cited
US4721110A
Cited
US4719921A
Cited
US4674518A
Cited
US4697591A
Cited
US4926862A
Cited
US4850357A
Cited
US4899750A
Cited
US5003975A
Cited
US4865036A
Cited
US5058583A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-12-29 | 1996-06-29 | 1996-12-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-12-29 | 2000-06-29 | 2000-12-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-12-29 | 2004-06-29 | 2004-12-29 | $7700.00 | Window Closed / Lapsed |